Rosuvastatin improves cardiovascular outcomes in thyroid disorder patients by reducing LDL cholesterol levels significantly, which is crucial since these patients are at increased risk for atherosclerosis.

Rosuvastatin offers additional benefits for thyroid patients by stabilizing plaque and reducing inflammation in arteries, beyond its potent lipid-lowering effects, which helps prevent cardiovascular events.